+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Advanced Wound Care Market Size, Share & Trends Analysis Report by Product (Moist, Antimicrobial, Active), Application (Chronic Wounds, Acute Wounds), End-use, Country, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 90 Pages
  • March 2024
  • Region: Europe
  • Grand View Research
  • ID: 5950090
The Europe advanced wound care market size is anticipated to reach USD 3.80 billion by 2030, expanding at a CAGR of 4.4% during the forecast period. The increasing incidence of injuries, the number of surgeries, and proportion of the geriatric population are the factors expected to drive the growth of this market. Moreover, the prevalence of chronic wounds such as diabetic foot ulcers is highly connected to the proportion of the geriatric population. According to Europe 2020 statistics presented by the OECD library, diabetes is more common in the geriatric population; approximately 19.3 million people in the age group of 60 to 79 have diabetes in several European countries, compared with 11.3 million people in the age group of 40 to 59 and only 1.7 million aged 20-39.

The presence of key players in the region, increasing focus on research and development (R&D), and partnerships between public and private players to provide better treatment options are further driving the market growth. For instance, in September 2023, Healiva, a company engaged in delivering precision medicine for chronic wounds, entered into collaboration with Lausanne University Hospital (CHUV, ‘Centre Hospitalier Universitaire Vaudois’), Switzerland, for the manufacturing and approval of its autologous epidermal equivalent, Epidex. The product offers a non-invasive treatment option for severe chronic venous leg ulcers (VLUs). This can provide an advanced treatment option for patients in Switzerland.

Europe Advanced Wound Care Market Report Highlights

  • Based on product, the moist wound care segment dominated the market with a revenue share of over70% in 2023, owing to its ability to maintain a suitable environment around the wound to facilitate tissue regeneration. On the other hand, the active wound care segment is expected to grow at the fastest CAGR over the forecast period.
  • Based on application, the chronic wounds segment held the largest revenue share of around 60% in 2023. The increasing prevalence of chronic diseases such as diabetes and, therefore increasing prevalence of chronic wounds are driving the growth of this market.
  • The acute wound segment is expected to grow at the fastest CAGR over the forecast period, due to the increasing number of surgical procedures.
  • The UK dominated the Europe advanced wound care industry owing to the presence of key players and technological developments in the country.
  • In March 2023, Bactiguard launched its wound care line in the UK and Ireland. The portfolio consists of several infection prevention solutions, including coated medical devices, coating technology, and biocompatible wound care products.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End-use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Europe Advanced Wound Care Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Advanced wound care Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Advanced wound care Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Europe Advanced wound care Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Moist
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2. Foam dressings
4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.3. Hydrocolloid dressings
4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.4. Film dressings
4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.5. Alginate dressings
4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.6. Hydrogel dressings
4.4.1.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.7. Collagen dressings
4.4.1.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.8. Other advanced dressings
4.4.1.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Antimicrobial
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.2. Silver
4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.3. Non-silver
4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Active
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.2. Biomaterials
4.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.3. Skin-substitute
4.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.4. Growth factors
4.4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Advanced wound care Market: Application Estimates & Trend Analysis
5.1. Application Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Europe Advanced wound care Market by Application Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Chronic wounds
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2. Diabetic foot ulcers
5.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3. Pressure ulcers
5.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.4. Venous leg ulcers
5.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.5. Other chronic wounds
5.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Acute wounds
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.2. Surgical & traumatic wounds
5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.3. Burns
5.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Europe Advanced Wound Care Market: End-use Estimates & Trend Analysis
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Europe Advanced Wound Care Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Hospitals
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Specialty clinics
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Home healthcare
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Others
6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Advanced wound care Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. France market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company heat map analysis, 2023
8.4. Company Profiles
8.4.1. ConvaTec Group PLC
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Smith+Nephew
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Mölnlycke Health Care AB
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. B. Braun Melsungen AG
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. 3M
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. URGO
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Coloplast Group
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Integra LifeSciences
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Medline Industries, Inc.
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. PAUL HARTMANN AG
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 Europe advanced wound care market, by region, 2018 - 2030 (USD Million)
Table 3 Europe advanced wound care market, by product, 2018 - 2030 (USD Million)
Table 4 Europe advanced wound care market, by application, 2018 - 2030 (USD Million)
Table 5 Europe advanced wound care market, by end-use, 2018 - 2030 (USD Million)
Table 6 UK advanced wound care market, by product, 2018 - 2030 (USD Million)
Table 7 UK advanced wound care market, by application, 2018 - 2030 (USD Million)
Table 8 UK advanced wound care market, by end-use, 2018 - 2030 (USD Million)
Table 9 Germany advanced wound care market, by product, 2018 - 2030 (USD Million)
Table 10 Germany advanced wound care market, by application, 2018 - 2030 (USD Million)
Table 11 Germany advanced wound care market, by end-use, 2018 - 2030 (USD Million)
Table 12 France advanced wound care market, by product, 2018 - 2030 (USD Million)
Table 13 France advanced wound care market, by application, 2018 - 2030 (USD Million)
Table 14 France advanced wound care market, by end-use, 2018 - 2030 (USD Million)
Table 15 Italy advanced wound care market, by product, 2018 - 2030 (USD Million)
Table 16 Italy advanced wound care market, by application, 2018 - 2030 (USD Million)
Table 17 Italy advanced wound care market, by end-use, 2018 - 2030 (USD Million)
Table 18 Spain advanced wound care market, by product, 2018 - 2030 (USD Million)
Table 19 Spain advanced wound care market, by application, 2018 - 2030 (USD Million)
Table 20 Spain advanced wound care market, by end-use, 2018 - 2030 (USD Million)
Table 21 Denmark advanced wound care market, by product, 2018 - 2030 (USD Million)
Table 22 Denmark advanced wound care market, by application, 2018 - 2030 (USD Million)
Table 23 Denmark advanced wound care market, by end-use, 2018 - 2030 (USD Million)
Table 24 Sweden advanced wound care market, by product, 2018 - 2030 (USD Million)
Table 25 Sweden advanced wound care market, by application, 2018 - 2030 (USD Million)
Table 26 Sweden advanced wound care market, by end-use, 2018 - 2030 (USD Million)
Table 27 Norway advanced wound care market, by product, 2018 - 2030 (USD Million)
Table 28 Norway advanced wound care market, by application, 2018 - 2030 (USD Million)
Table 29 Norway advanced wound care market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Europe advanced wound care market: Market outlook
Fig. 8 Europe advanced wound care competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Europe advanced wound care market driver impact
Fig. 13 Europe advanced wound care market restraint impact
Fig. 14 Europe advanced wound care market: Product movement analysis
Fig. 15 Europe advanced wound care market: Product outlook and key takeaways
Fig. 16 Moist market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 17 Foam dressings market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Hydrocolloid dressings market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Film dressings market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Alginate dressings market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Hydrogel dressings market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Collagen dressings market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Other advanced dressings market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Antimicrobial ablation estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Silver market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Non-silver market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Active market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Skin-substitute market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Growth factors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Advanced wound care Market: Application movement Analysis
Fig. 32 Advanced wound care market: Application outlook and key takeaways
Fig. 33 Chronic wounds market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Diabetic ulcers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Pressure ulcers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Venous leg ulcers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Other chronic wounds market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Acute wounds market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Surgical & traumatic wounds market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Burns market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Advanced wound care market: End-use movement analysis
Fig. 42 Advanced wound care market: End-use outlook and key takeaways
Fig. 43 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Specialty clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Home healthcare market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Europe advanced wound care market: Regional movement analysis
Fig. 48 Europe advanced wound care market: Regional outlook and key takeaways
Fig. 49 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 UK
Fig. 51 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Germany
Fig. 53 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 France
Fig. 55 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Italy
Fig. 57 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Spain
Fig. 59 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Denmark
Fig. 61 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Sweden
Fig. 63 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Norway
Fig. 65 Norway market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • ConvaTec Group PLC
  • Smith+Nephew
  • Mölnlycke Health Care AB
  • B. Braun Melsungen AG
  • 3M
  • URGO
  • Coloplast Group
  • Integra LifeSciences
  • Medline Industries, Inc.
  • PAUL HARTMANN AG

Methodology

Loading
LOADING...

Table Information